Impact of combined CYP2C19/CYP2B6 phenotypes on sertraline dose-normalized concentration and antidepressant switching incidence: A retrospective cohort study in Chinese Han population.
Sertraline, a commonly used first-line antidepressant for major depressive disorder, is primarily metabolized by the polymorphic cytochrome P450 enzymes CYP2C19 and CYP2B6. This large-scale Chinese cohort study (N = 1070 patients; 1414 serum concentration measurements) evaluated whether incorporating CYP2B6 phenotype p...